Our data demonstrate that high VEGF-C expression leads to an increase in the TIC population, an altered cellular response to ROS and an increase in resistance to chemotherapy, all likely contributing to its ability to enhance tumor progression. The gene discussed is VEGFC; the disease is neoplasm.